STRIDES TOWARDS THE FUTURE
Animal models have indicated that when treated with our MiroRNA technology, wounds close 30-50% faster. The tissue generated to close the wound is virtually identical to the tissue it replaced. This makes our technology a sustainable and scalable SKIN REGENERATION SOLUTION
Status: Pre-IND, with 2 independent animal models completed
Accelerated scarless healing and closure of
surgical, traumatic and chronic wounds
Decreases wound infections, post-op hospital stays
Prevents amputations of limbs as a consequence of non healing wounds - Saves the healthcare industry billions of dollars per year worldwide.
Prevents scar formation
Used in surgical procedures
Reduces multiple complications contractions of burn patients and adhesions (internal scarring)
The compound can be lyophilized
Improves its application to any dry wound healing product.
In its standard form, it can be added to antibiotic ointments, solutions for washing wounds, gels and topical sprays, all critical to wound healing.
Advanced applications include the inclusion of the compound in collagen matrixes used for complex wounds with exposed tendons and bones, in addition to dermal cadaver matrixes for repair of soft tissue defects and hernias.
Integration with other technologies:
The potential to be used in standalone form or in conjunction with other advanced technologies, allowing for cross development and update of legacy products